A Blood Test for Better Prostate Cancer Diagnostics
Investigators found that the test was able to distinguish cancer localized to the prostate from cancer that spread to other parts of the body.
Read More
Search Results for: prostate cancer
FDA Clears Cytovale’s IntelliSep Sepsis Test
Cytovale, a medical diagnostics company focused on advancing early detection technologies, announced that its IntelliSep test has received U.S. Food and Drug Administration (FDA) 510(k) clearance to aid in the early detection of sepsis.
Read More
Patent Issued for Early Detectable Blood-Based Biomarker for Alzheimer’s
A U.S. patent that focuses on the development of a novel blood-based biomarker for the early detection of Alzheimer’s has been issued.
Read More
Micronoma Gets Breakthrough Device Designation for Liquid Biopsy Assay that Detects Lung Carcinoma
Micronoma announced its OncobiotaLUNG assay received the Breakthrough Device Designation from the U.S. FDA for lung carcinoma detection.
Read More
Prostate Screening Tests Used Even if They Don’t Provide Value
Shifting guidelines for prostate cancer screening lead to uncertainty on when and if prostate screening tests should be ordered.
Read More